Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis

NCT02245841 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02245841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02245841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
June 15, 2015
Completion date
July 14, 2021
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatomyositis, juvenile dermatomyositis